ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 89 filers reported holding ENZO BIOCHEM INC in Q4 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,911,000 | +58.2% | 1,284,014 | +16.0% | 0.00% | +100.0% |
| Q3 2016 | $5,632,000 | -8.5% | 1,106,528 | +7.3% | 0.00% | 0.0% |
| Q2 2016 | $6,154,000 | +1430.8% | 1,030,773 | +1067.3% | 0.00% | – |
| Q1 2016 | $402,000 | -5.9% | 88,301 | -6.9% | 0.00% | – |
| Q4 2015 | $427,000 | +48.8% | 94,875 | +4.9% | 0.00% | – |
| Q3 2015 | $287,000 | -9.7% | 90,428 | -13.8% | 0.00% | – |
| Q2 2015 | $318,000 | -89.3% | 104,881 | -89.6% | 0.00% | -100.0% |
| Q1 2015 | $2,969,000 | -32.2% | 1,006,579 | +2.0% | 0.00% | 0.0% |
| Q4 2014 | $4,382,000 | +3.6% | 986,831 | +20.1% | 0.00% | 0.0% |
| Q3 2014 | $4,231,000 | -5.9% | 821,593 | -4.0% | 0.00% | 0.0% |
| Q2 2014 | $4,494,000 | +962.4% | 856,016 | +741.4% | 0.00% | – |
| Q1 2014 | $423,000 | +42.9% | 101,734 | +0.4% | 0.00% | – |
| Q4 2013 | $296,000 | +20.8% | 101,281 | +4.4% | 0.00% | – |
| Q3 2013 | $245,000 | +31.7% | 97,051 | +8.4% | 0.00% | – |
| Q2 2013 | $186,000 | – | 89,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |